Brief: Nucana Says Data From Nutide:701 Shows Favorable Safety And Tumor Reduction
18/10/2025 13:05
Oct 18 (Reuters) - NuCana PLC NCNA.O: NUCANA PRESENTS ENCOURAGING DATA ON NUC-7738 IN COMBINATION WITH PD-1 INHIBITORS USING PRIMARY PATIENT-DERIVED ORGANOIDS AND AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES AT THE ESMO CONGRESS 2025 NUCANA PLC - REGULATORS APPROVE STUDY EXPANSION FOR 28 MORE PATIENTS NUCANA PLC - DATA TO DATE FROM NUTIDE:701 SHOWS FAVORABLE SAFETY AND TUMOR REDUCTION Source text: ID:nGNX8CdlGH Further company coverage: NCNA.O ((Reuters.Briefs@thomsonreuters.com;))